These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Polycyclic aromatic hydrocarbons and dibutyl phthalate disrupt dorsal-ventral axis determination via the Wnt/β-catenin signaling pathway in zebrafish embryos. Fairbairn EA; Bonthius J; Cherr GN Aquat Toxicol; 2012 Nov; 124-125():188-96. PubMed ID: 22975441 [TBL] [Abstract][Full Text] [Related]
4. Identification of novel scaffold of benzothiazepinones as non-ATP competitive glycogen synthase kinase-3β inhibitors through virtual screening. Zhang P; Hu HR; Huang ZH; Lei JY; Chu Y; Ye DY Bioorg Med Chem Lett; 2012 Dec; 22(23):7232-6. PubMed ID: 23099099 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of glycogen synthase kinase 3β induces dermal fibrosis by activation of the canonical Wnt pathway. Bergmann C; Akhmetshina A; Dees C; Palumbo K; Zerr P; Beyer C; Zwerina J; Distler O; Schett G; Distler JH Ann Rheum Dis; 2011 Dec; 70(12):2191-8. PubMed ID: 21873331 [TBL] [Abstract][Full Text] [Related]
6. Structure-based design of benzo[e]isoindole-1,3-dione derivatives as selective GSK-3β inhibitors to activate Wnt/β-catenin pathway. Yue H; Lu F; Shen C; Quan JM Bioorg Chem; 2015 Aug; 61():21-7. PubMed ID: 26057861 [TBL] [Abstract][Full Text] [Related]
8. GSK-3β suppresses the proliferation of rat hepatic oval cells through modulating Wnt/β-catenin signaling pathway. Ji XK; Xie YK; Zhong JQ; Xu QG; Zeng QQ; Wang Y; Zhang QY; Shan YF Acta Pharmacol Sin; 2015 Mar; 36(3):334-42. PubMed ID: 25661318 [TBL] [Abstract][Full Text] [Related]
9. Analysis of Glycogen Synthase Kinase Inhibitors That Regulate Cytochrome P450 Expression in Primary Human Hepatocytes by Activation of β-Catenin, Aryl Hydrocarbon Receptor and Pregnane X Receptor Signaling. Briolotti P; Chaloin L; Balaguer P; Da Silva F; Tománková V; Pascussi JM; Duret C; Fabre JM; Ramos J; Klieber S; Maurel P; Daujat-Chavanieu M; Gerbal-Chaloin S Toxicol Sci; 2015 Nov; 148(1):261-75. PubMed ID: 26259606 [TBL] [Abstract][Full Text] [Related]
10. Novel benzothiazinones (BTOs) as allosteric modulator or substrate competitive inhibitor of glycogen synthase kinase 3β (GSK-3β) with cellular activity of promoting glucose uptake. Zhang P; Li S; Gao Y; Lu W; Huang K; Ye D; Li X; Chu Y Bioorg Med Chem Lett; 2014 Dec; 24(24):5639-5643. PubMed ID: 25467150 [TBL] [Abstract][Full Text] [Related]
11. 2,3,7,8-TCDD induces neurotoxicity and neuronal apoptosis in the rat brain cortex and PC12 cell line through the down-regulation of the Wnt/β-catenin signaling pathway. Xu G; Zhou Q; Wan C; Wang Y; Liu J; Li Y; Nie X; Cheng C; Chen G Neurotoxicology; 2013 Jul; 37():63-73. PubMed ID: 23619006 [TBL] [Abstract][Full Text] [Related]
12. Nuclear GSK-3beta inhibits the canonical Wnt signalling pathway in a beta-catenin phosphorylation-independent manner. Caspi M; Zilberberg A; Eldar-Finkelman H; Rosin-Arbesfeld R Oncogene; 2008 Jun; 27(25):3546-55. PubMed ID: 18223684 [TBL] [Abstract][Full Text] [Related]
13. A new protocol for predicting novel GSK-3β ATP competitive inhibitors. Fang J; Huang D; Zhao W; Ge H; Luo HB; Xu J J Chem Inf Model; 2011 Jun; 51(6):1431-8. PubMed ID: 21615159 [TBL] [Abstract][Full Text] [Related]
14. BDNF promotes the growth of human neurons through crosstalk with the Wnt/β-catenin signaling pathway via GSK-3β. Yang JW; Ru J; Ma W; Gao Y; Liang Z; Liu J; Guo JH; Li LY Neuropeptides; 2015 Dec; 54():35-46. PubMed ID: 26311646 [TBL] [Abstract][Full Text] [Related]
15. Molecular dynamics simulation studies of GSK-3β ATP competitive inhibitors: understanding the factors contributing to selectivity. Arfeen M; Patel R; Khan T; Bharatam PV J Biomol Struct Dyn; 2015; 33(12):2578-93. PubMed ID: 26209183 [TBL] [Abstract][Full Text] [Related]
16. Altered Wnt signalling in the teenage suicide brain: focus on glycogen synthase kinase-3β and β-catenin. Ren X; Rizavi HS; Khan MA; Dwivedi Y; Pandey GN Int J Neuropsychopharmacol; 2013 Jun; 16(5):945-55. PubMed ID: 23110823 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells. Gao Y; Liu Z; Zhang X; He J; Pan Y; Hao F; Xie L; Li Q; Qiu X; Wang E Cancer Lett; 2013 Aug; 336(1):231-9. PubMed ID: 23673211 [TBL] [Abstract][Full Text] [Related]
18. Protein kinase C inhibits amyloid beta peptide neurotoxicity by acting on members of the Wnt pathway. Garrido JL; Godoy JA; Alvarez A; Bronfman M; Inestrosa NC FASEB J; 2002 Dec; 16(14):1982-4. PubMed ID: 12397090 [TBL] [Abstract][Full Text] [Related]
19. Glycogen synthase kinase-3 beta inhibitor suppresses Porphyromonas gingivalis lipopolysaccharide-induced CD40 expression by inhibiting nuclear factor-kappa B activation in mouse osteoblasts. Die L; Yan P; Jun Jiang Z; Min Hua T; Cai W; Xing L Mol Immunol; 2012 Aug; 52(1):38-49. PubMed ID: 22580404 [TBL] [Abstract][Full Text] [Related]